US Stock MarketDetailed Quotes
AMIX Autonomix Medical
- 6.280
- -7.240-53.55%
Close Nov 22 16:00 ET
- 6.450
- +0.170+2.71%
Post 20:02 ET
7.24MMarket Cap-515P/E (TTM)
6.660High5.850Low945.99KVolume6.200Open13.520Pre Close6.21MTurnover145.78%Turnover RatioLossP/E (Static)1.15MShares152.00052wk High2.39P/B4.08MFloat Cap5.85052wk Low--Dividend TTM648.91KShs Float152.000Historical High--Div YieldTTM5.99%Amplitude5.850Historical Low6.562Avg Price1Lot Size
Autonomix Medical Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 124.37%2.84M | 216.07%2.75M | 275.58%7.47M | 267.73%2.42M | 437.50%2.92M | 1.26M | 871K | 1.99M | 657K | 544K |
| Selling and administrative expenses | 109.58%1.66M | 257.65%1.8M | 321.61%5.25M | 530.00%1.58M | 573.33%2.32M | --793K | --503K | --1.25M | --250K | --345K |
| -General and administrative expense | 109.58%1.66M | 257.65%1.8M | 321.61%5.25M | 530.00%1.58M | 573.33%2.32M | --793K | --503K | --1.25M | --250K | --345K |
| Research and development costs | 149.26%1.17M | 159.24%954K | 198.66%2.23M | 106.63%841K | 202.01%601K | --471K | --368K | --745K | --407K | --199K |
| Operating profit | -124.37%-2.84M | -216.07%-2.75M | -275.58%-7.47M | -267.73%-2.42M | -437.50%-2.92M | -1.26M | -871K | -1.99M | -657K | -544K |
| Net non-operating interest income expense | 52.63%29K | 800.00%54K | 48K | 34K | -10K | 19K | 6K | 0 | 0 | 0 |
| Non-operating interest income | 278.95%72K | 1,483.33%95K | --127K | --80K | --23K | --19K | --6K | --0 | --0 | --0 |
| Non-operating interest expense | --43K | --41K | --79K | --46K | --33K | --0 | --0 | --0 | --0 | --0 |
| Other net income (expense) | -8M | -3.03M | -179K | -4.8M | ||||||
| Gain on sale of security | ---- | ---- | ---8M | ---3.03M | ---179K | ---4.8M | ---- | ---- | ---- | ---- |
| Income before tax | 53.53%-2.81M | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | -472.24%-3.11M | -6.04M | -865K | -1.99M | -657K | -544K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | 53.53%-2.81M | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | -472.24%-3.11M | -6.04M | -865K | -1.99M | -657K | -544K |
| Net income continuous Operations | 53.53%-2.81M | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | -472.24%-3.11M | ---6.04M | ---865K | ---1.99M | ---657K | ---544K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 53.53%-2.81M | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | -472.24%-3.11M | -6.04M | -865K | -1.99M | -657K | -544K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 53.53%-2.81M | -212.02%-2.7M | -675.18%-15.43M | -723.14%-5.41M | -472.24%-3.11M | -6.04M | -865K | -1.99M | -657K | -544K |
| Basic earnings per share | 56.82%-2.47 | -241.79%-2.8 | -1,014.26%-21 | -822.36%-5.7391 | -472.24%-2.9482 | -5.7203 | -0.8192 | -1.8847 | -0.6222 | -0.5152 |
| Diluted earnings per share | 56.82%-2.47 | -241.79%-2.8 | -1,014.26%-21 | -822.36%-5.7391 | -472.24%-2.9482 | -5.7203 | -0.8192 | -1.8847 | -0.6222 | -0.5152 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data